doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 145
2021
-
Gliblastom: fenomén rychlé progrese před zahájením adjuvantní léčby
Year: 2021, type: Conference abstract
-
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
Cancers, year: 2021, volume: 13, edition: 7, DOI
-
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
Journal of clinical oncology, year: 2021, volume: 39, edition: 9, DOI
-
Proteotypová analýza renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi
Year: 2021, type: Appeared in Conference without Proceedings
-
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Medicine, year: 2021, volume: 100, edition: 24, DOI
-
Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
Biomedicines, year: 2021, volume: 9, edition: 9, DOI
2020
-
Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy-Data from the National Renis Registry
Cancers, year: 2020, volume: 12, edition: 10, DOI
-
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)
MELANOMA RESEARCH, year: 2020, volume: 30, edition: 3, DOI
-
Dlouhé nekódující RNA a karcinom z renálních buněk
Klinická onkologie, year: 2020, volume: 33, edition: 5, DOI
-
Doporučené postupy pro časnou detekci, diagnostiku a léčbu jednotlivých stádií karcinomu prostaty
Year: 2020